Biotech companies covered by this survey are grouped according to the following sectors:

• BioPharma: includes vaccines, therapeutics and diagnostics
• BioAgri: includes genetically modified seeds, molecular markers and related products
• BioServices: includes contract research and manufacturing services (CRAMS) and clinical research services
• BioIndustrial: includes enzymes for food, leather and textiles, pharmaceuticals, detergents and energy applications
• BioInformatics: includes information technologies to develop tools for drug discovery, and informatics based services

Based on a detailed questionnaire sent to over 200 companies, the annual survey captures the revenues – biotech products sales and service figures – or, if not available, relies on best estimates.

As in previous years, the Indian biotech industry is dominated by the BioPharma sector, which accounts for 63.5 % market share, followed by BioServices (18.5 %), BioAgri (13.6 %), BioIndustry (3.2 %) and BioInformatics (1.2 %). The differences in growth rates are significant, with BioPharma (17.7%) and BioServices (15.5%) leading the industry, followed by BioIndustrial (10.9%), BioInformatics (9.1%) and BioAgri (5.2%).

Figures for export (2,01 Billion US$) slightly exceeded domestic sales (1.93 Billion US$). Among exports, BioPharma (65 % of total exports) and BioServices (32 %) outweigh by far the other sectors with 1-2 % market share each.

The overall biotech industry registered on average 14.5 % annual growth over the last five years.
 
For details of this survey, please visithttp://www.biospectrumindia.com, orhttp://www.ableindia.in